Publications

  • Hermida, N., B. Lopez, A. Gonzalez, J. Dotor, J. J. Lasarte, P. Sarobe, F. Borras-Cuesta, and J. Diez.* 2009. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovasc Res 81:601-609. IF 6.113; Lugar: 12/124; Cardiac and cardiovas- cular systems; 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Llopiz, D., J. Dotor, N. Casares, J. Bezunartea, N. Diaz-Valdes, M. Ruiz, F. Aranda, P. Berraondo, J. Prieto, J. J. Lasarte, F. Borras-Cuesta, and P. Sarobe.* 2009. Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy. Int J Cancer 125:2614-2623. IF 5.474; Lugar: 23/197; On- cology; 1er  cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Casares, N., F. Rudilla, L. Arribillaga, D. Llopiz, J. I. Riezu-Boj, T. Lozano, J. Lopez-Sagaseta, L. Guembe, P. Sarobe, J. Prieto, F. Borras-Cuesta, and J. J. Lasarte.* 2010. A peptide inhibitor of FOXP3 impairs regula- tory T cell activity and improves vaccine efficacy in mice. J Immunol 185:5150-5159. IF 5.860; Lugar: 24/137; Immunology; 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Diaz-Valdes, N., M. Basagoiti, J. Dotor, F. Aranda, I. Monreal, J. I. Riezu-Boj, F. Borras-Cuesta, P. Sarobe, and E. Feijoo.* 2011. Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression. Cancer Res 71:812-821. IF 8.576; Lugar: 11/197; Oncology; 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Diaz-Valdes, N., L. Manterola, V. Belsue, J. I. Riezu-Boj, E. Larrea, I. Echeverria, D. Llopiz, J. Lopez-Sagas- eta, H. Lerat, J. M. Pawlotsky, J. Prieto, J. J. Lasarte, F. Borras-Cuesta, and P. Sarobe.* 2011. Improved den- dritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10. Hepatology 53:23-31. IF 11.4; Lugar: 2/74; Gastroenterology and hepatology; 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED



""We have shown the different strategies that potentiate the activation the dendritic cells increase the effect of the vaccines. This has given rise to different vaccination protocols, which have been trialed in patients", Dr. Pablo Sarobe, Principal Investigator.

More information:

Contact

Contact:
Cristina Canciani
Avda. Pío XII, 53
31008 Pamplona
Spain

(+34) 948 194 700 Ext. 2013
canciani@unav.es